Swiss Consumer Finance Stock News

Kuros Biosciences recently raised its 2025 annual guidance, reporting a 77% increase in revenue for the first nine months and announcing new product milestones, including FDA clearance and commercial launch of the MagnetOs MIS Delivery System in the U.S. as well as regulatory approval in Saudi Arabia. These achievements highlight the company's accelerated international expansion and increasing commercial traction in both the U.S. and MENA regions. We'll explore how Kuros Biosciences' rapid...

If you find yourself wondering what to do next with Roche Holding, you are not alone. The stock has been on a bit of a ride lately, with a strong 8.9% pop over the last month that has turned heads and reignited conversations about its longer-term potential. While there was a slight dip this past week at -2.2%, Roche is still up 10.6% year-to-date and 7.2% over the past year, which highlights its staying power in a changing pharmaceutical landscape. Much of the recent attention can be traced...

ARYZTA (SWX:ARYN) saw a major boardroom update as CEO Michael Schai stepped down with immediate effect. Chairman Urs Jordi has taken over as interim CEO. The company also reaffirmed its 2025 earnings and organic growth guidance. See our latest analysis for ARYZTA. ARYZTA’s announcement of a new interim CEO arrives as the share price faces pressure, down nearly 28% over the past month and off 35% in the last three months. This signals fading momentum despite stable long-term direction. Still,...

Sonova Holding (SWX:SOON) shares have attracted fresh attention as investors weigh recent returns and current valuation. The stock has seen pressure over the past month, which raises questions about its outlook. See our latest analysis for Sonova Holding. With Sonova Holding’s share price retreating over the past month, recent momentum is clearly cooling off. The latest close at CHF 217.4 comes after a 1-month share price return of -7.5 percent and a year-to-date drop of 26.7 percent. Over...

Earlier this week, Nestlé announced plans to cut 16,000 jobs globally, 6% of its workforce, with 12,000 reductions coming from white-collar roles, as part of an expanded cost-saving program under new CEO Philipp Navratil. This move follows stronger than expected sales growth and signals a push to accelerate operational efficiency and organizational transformation at the world’s largest food company. We'll take a closer look at how this major restructuring effort under the new CEO could...

On October 16, 2025, UBS Group AG announced the appointment of Daniele Magazzeni as Chief Artificial Intelligence Officer to lead its AI strategy and drive technological transformation; Magazzeni brings experience from J.P. Morgan and academia, with his new role commencing January 1, 2026. This move highlights UBS's commitment to advancing AI adoption to enhance client engagement and employee productivity through the scaled deployment of innovative technology solutions. We'll explore how...

One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...

The Ypsomed Holding AG ( VTX:YPSN ) share price has fared very poorly over the last month, falling by a substantial...

Shareholders in Kuros Biosciences AG ( VTX:KURN ) may be thrilled to learn that the covering analyst has just delivered...

dormakaba Holding AG's ( VTX:DOKA ) dividend will be increasing from last year's payment of the same period to CHF9.20...

Earlier this week, Sulzer reported a 1.2% year-to-date order intake decline, with strong services growth offset by delayed projects and weaker demand, especially in Chemtech and China. This mixed performance highlights significant divergence between Sulzer's business units, suggesting the company faces ongoing sector- and region-specific challenges even as it reaffirms growth guidance. To understand how Sulzer's strong services division growth affects its investment outlook, we will explore...

If you have been following Logitech International or are considering adding it to your portfolio, you are not alone in wondering what comes next for this long-standing tech player. Logitech’s stock recently closed at $86.02, and although the past month brought a modest pullback of -2.8%, the year-to-date gain stands strong at 14.8%. If you widen the lens, the stock is up an impressive 102.7% over the last three years, a testament to market confidence as Logitech adapts to shifting workplace...

With its stock down 6.8% over the past three months, it is easy to disregard Bucher Industries (VTX:BUCN). However...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights SGS' estimated fair value is CHF137 based on 2 Stage Free Cash Flow to Equity SGS' CHF87.24 share price...

ABB (SWX:ABBN) posted net profit margins of 12.5%, up from last year’s 11.8%, and has delivered average annual earnings growth of 22% over the past five years. However, the most recent year-over-year earnings growth trimmed to 9.8%, with future earnings now forecast to rise at 6.99% per year, which is notably trailing the Swiss market’s 10.8% average growth outlook. While investors can point to ABB’s strong ongoing profit and revenue growth as key rewards, the combination of moderating growth...

Nestlé (SWX:NESN) shares have edged slightly higher this week, with investors taking note of the company’s modest but steady performance. The stock’s movement comes as market participants assess healthy annual gains in both revenue and net income. See our latest analysis for Nestlé. While Nestlé's share price has inched higher this week, that movement follows a broader trend. Despite healthy revenue and net income growth, momentum has struggled to build. The stock has gained just under 2%...

Alcon (SWX:ALC) stock has edged up slightly in the latest trading session, following a period of underperformance over the past month. Investors are taking a closer look at how the company's fundamentals might influence its near-term outlook. See our latest analysis for Alcon. While Alcon’s share price has slipped more than 21% so far this year and is down 14% over the past three months, the longer-term picture is less discouraging, with a 3-year total shareholder return of 2.6% and 5-year...

Medartis Holding AG ( VTX:MED ) shareholders might be concerned after seeing the share price drop 11% in the last...

If you are debating what to do with your Novartis shares or considering jumping in, you are not alone. The stock has been a topic of conversation among investors thanks to its impressive mix of stability and recent upward momentum. Just look at the numbers, and you will see Novartis is up 16.9% for the year to date and a striking 60.2% over three years. Shorter-term movement can be choppier, as seen in the last week’s modest 2.3% dip. This is hardly surprising given some pockets of cautious...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

As European markets experience a pullback from recent record highs, driven by political turmoil in France and renewed global trade tensions, investors are keenly observing the region for potential opportunities. In this environment of uncertainty, identifying undervalued stocks becomes crucial as these may offer attractive entry points for those looking to capitalize on discrepancies between market price and intrinsic value.

Interroll Holding AG ( VTX:INRN ), might not be a large cap stock, but it saw a decent share price growth of 17% on the...